Episode 32: Dr. Nadia Ahmad Part 1 - Obesity Care Is More Than a Prescription

This is part 2. Nichole spent decades thinking about food. Not because she lacked discipline. Not because she wasn't trying hard enough. But because her biology was constantly fighting back. In this episode, she shares her journey from binge eating disorder and a peak weight of nearly 400 pounds to losing 110 pounds with tirzepatide. But the biggest change wasn't the weight. It was the silence. This podcast shares lived experiences and opinions. It’s for informational purposes only and not medical advice. Always talk to your healthcare provider for personal medical guidance.

This is part 1. Nichole spent decades thinking about food. Not because she lacked discipline. Not because she wasn't trying hard enough. But because her biology was constantly fighting back. In this episode, she shares her journey from binge eating disorder and a peak weight of nearly 400 pounds to losing 110 pounds with tirzepatide. But the biggest change wasn't the weight. It was the silence. This podcast shares lived experiences and opinions. It’s for informational purposes only and not medical advice. Always talk to your healthcare provider for personal medical guidance.

This is part 2. As a climate scientist, researcher, and lifelong problem-solver, Meighan spent years doing what she was told should work. She exercised. She learned about nutrition. She worked harder. Yet obesity continued to take up more and more space in her life—not just physically, but mentally. In this conversation, we explore the concept of capacity: the energy, focus, resilience, and mental bandwidth that obesity quietly consumes. Meighan shares how years of constant hunger, burnout, anxiety, weight stigma, and self-blame affected her ability to show up in her career, relationships, and everyday life. After discovering a B12 deficiency and starting Mounjaro, she experienced something unexpected. Not just weight loss, but the return of mental clarity, physical capability, and a sense of ease she hadn't felt in decades. Together, we discuss why society often treats suffering as proof of effort, why obesity deserves more empathy, and what becomes possible when managing your weight no longer requires all of your attention. This episode isn't really about losing weight. It's about what happens when you finally get some of your life back.

THIS IS PART ONE! As a climate scientist, researcher, and lifelong problem-solver, Meighan spent years doing what she was told should work. She exercised. She learned about nutrition. She worked harder. Yet obesity continued to take up more and more space in her life—not just physically, but mentally. In this conversation, we explore the concept of capacity: the energy, focus, resilience, and mental bandwidth that obesity quietly consumes. Meighan shares how years of constant hunger, burnout, anxiety, weight stigma, and self-blame affected her ability to show up in her career, relationships, and everyday life. After discovering a B12 deficiency and starting Mounjaro, she experienced something unexpected. Not just weight loss, but the return of mental clarity, physical capability, and a sense of ease she hadn't felt in decades. Together, we discuss why society often treats suffering as proof of effort, why obesity deserves more empathy, and what becomes possible when managing your weight no longer requires all of your attention. This episode isn't really about losing weight. It's about what happens when you finally get some of your life back.

In this episode, I’m joined by Dr. Ian Ellis, a board-certified emergency medicine physician who believes we may be approaching GLP-1 dosing the wrong way. Instead of automatically escalating patients toward higher and higher doses, Dr. Ellis focuses on finding each person’s individual therapeutic window — enough medication to make weight loss possible, without suppressing appetite to the point where eating, exercising and getting adequate nutrition become difficult. We talk about why more medication doesn’t necessarily mean better results, side effects, muscle loss, semaglutide vs. tirzepatide, maintenance and whether everyone really needs to stay on GLP-1 medication for life. Ian also shares his own experience with obesity and semaglutide — and how that eventually led him to develop a mathematical approach to precision dosing and an app designed to help clinicians individualize treatment.